MetLife Investment Advisors »

Definium Therape shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 54k 18.90

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
State Street Spdr S&p Etf Trust Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Exxon Mobil Corporation (XOM)

View all positions for MetLife Investment Advisors

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape